De Hoe Chye

The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody

Conrad En Zuo Chan, Shirley G. K. Seah, De Hoe Chye et al. · PLoS ONE · 2021 · 106 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

<scp>IDentif</scp> . <scp>AI</scp> : Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐Cov‐2) with digital drug development

Agata Blasiak, Jhin Jieh Lim, Shirley Gek Kheng Seah et al. · Bioengineering & Translational Medicine · 2020 · 44 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +16

The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody

Conrad En Zuo Chan, Shirley G. K. Seah, De Hoe Chye et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 32 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine

David Skibinski, Brendon J. Hanson, Yu-Fang Lin et al. · PLoS ONE · 2013 · 29 citations · Full text

Pharmacy, Immunology, Immunization +13

The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens

Agata Blasiak, Anh T. L. Truong, Alexandria Remus et al. · npj Digital Medicine · 2022 · 27 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +16